Complete headline results for Commercial Deal, when?, page-258

BIT has been after the HIV cure for 20 years - and I hope they continue.

If they can get their focus back on that - and maybe investigate the anti-viral qualities of BIT225, they they have a good chance moving forward.

Dare I say it, a CR will be required, and I do hope they will be knocking on doors to get some support from third parties.

HIV results were "promising" but not definitive. I don't think they can extract any new information from the trials - and the language used when presenting the results was quite subdued.

I wish that BIT would be a bit more proactive.